Teva (TEVA) has received a subpoena from the SEC over its compliance with U.S. anti foreign...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Teva (TEVA) has received a subpoena from the SEC over its compliance with U.S. anti foreign bribery laws in Latin America, the company said in a regulatory filing last week. A Reuters investigation has found that eight of the world's top 10 drug firms have warned of potential expenses connected to possible corruption overseas.